Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

AACR: Novel Approach Prevents Cancer Progression, Spares Surgery for Majority of Patients with Precancerous Oral Lesions

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from surgery. This new research from The University of Texas MD Anderson Cancer Center suggests a novel approach to oral cancer prevention through immune interception.

April 21, 2026


April 21 2026

April 20 2026

April 19 2026

April 18 2026

April 17 2026

April 16 2026

April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026